Rituximab
Rituximab
Long Term Use & Adverse Effects
Originally approved as anti-cancer agent in 1997, Rituximab (abbreviated RTX) is a monoclonal antibody broadly classified as a so-called biologic drug. Biologics such as RTX are targeted
Read more
Media included
Price:
$399
Buy now
Or partners log in and checkout with
Rituximab
Rituximab
Long Term Use & Adverse Effects
Research Guides
Price
0.25 engagement credits
Order now
Complete the form below to access the Rituximab document in Expert IQ
Unlock unlimited access to every litigation research document
With a subscription to our Research Guide Library, you can access all the medico-legal research you need at significantly reduced rates.
Subscribe and save
Your information will not be shared. View our privacy policy.